Clinical Trials Browser

Cannabidiol × 90 days × Clear all

NCT05485831 2026-06-03

EpiTALY

Active not recruiting

Epilepsies, Myoclonic, Seizures, Tuberous Sclerosis, Lennox Gastaut Syndrome

NCT05044819 2026-06-01

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

Phase 4 Active not recruiting

Epilepsies, Myoclonic, Liver Cirrhosis, Tuberous Sclerosis, Lennox Gastaut Syndrome

NCT06538389 2026-04-30

High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer

Phase 2 Recruiting

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT05864846 2026-04-27

EpiCom

Phase 4 Completed

Behavior, Seizures, Tuberous Sclerosis

NCT07549256 2026-04-24

ProCan

Phase 2 Not yet recruiting

Marijuana Abuse, Prostatic Neoplasms

NCT06533657 2026-04-21

UTOPIA-1

Phase 2 Completed

Cancer Pain

NCT05836857 2026-04-16

The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study

Active not recruiting

Neoplasms

NCT05753007 2026-03-16

A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients

Phase 2 Terminated

2 enrolled 13 charts

Glioblastoma